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1. Introduction 
The basic encephalitogenic protein, which is a 
major component of the central nervous system 
myelin and is often referred to as the Al protein [ 11, 
has recently attracted considerable attention. When 
minute amounts are injected into animals, it has the 
property of inducing a disease, experimental allergic 
encephalomyelitis (EAE), which has often been taken 
as an animal model for human demyelinating diseases, 
notably multiple sclerosis. The experimental disease 
is usually considered to be due to cell-mediated 
immunity against the basic protein [2] . The sequence 
of the protein, or fragments of it, has recently been 
determined in three different laboratories [ 1, 3-71. 
A number of small regions of the protein have proved 
capable of inducing the disease. Considerable species 
variability in the response to these regions seems to 
exist. Guinea-pigs respond almost exclusively to a 
region composed of nine amino acids (residues 114- 122 
in the bovine protein) and containing the single tryp- 
tophan residue of the protein [4,7-lo]. Borderline 
activity has been ascribed to three more regions; one 
within residues I-20 [4,9, 111, one within residues 
44- 116 [ 121 (or even within residues 44-89 [ 13]), 
and one site in region 117- 170 [ 121. On the other 
hand, rabbits respond much more vigorously to these 
regions. Fragment 44-89 is a major encephalitogenic 
region when tested in rabbits [6,7, 11, 131, and 
region 117- 170 has been found to have considerable 
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activity [ 141. When monkeys are used as experimental 
animals, region 44-89 seems to be fully active [ 111, 
whereas the tryptophan containing determinant is not 
[ 11, 121 . However, inability to create disease in 
monkeys with region 44-89 has been reported [ 121. 
In this communication, we extend previous studies 
concerning the encephalitogenic activity of the 
C-terminal region of the bovine protein when tested 
in rabbits. We present evidence that there are at least 
two different disease-inducing sites in this part of the 
protein localized within the sequences 134-150 and 
154-170, respectively. 
2. Experimental methods and results 
The preparation and isolation of region 117- 170, 
using oxidation of the native protein or the fragment 
44-170 with the bromine adduct of 2-(2-nitrophenyl- 
sulphenyl)3-methylindole and CM-Sephadex chroma- 
tography and gel filtration of the reaction products, 
has previously been described [ 14, 151. To 12.5 mg of 
this peptide, dissolved in 15 ml acetic acid pH 3, 1 mg 
of pepsin (Sigma P 6875) was added, and the reaction 
was allowed to proceed at 37” for 3 hr. The reaction 
products were lyophilized and dissolved in 1 ml 0.25 M 
ammonium acetate buffer pH 5 (core material was 
centrifuged away). They were first fractionated on 
Sephadex G-50 superfine (1.5 X 89 cm). The column 
was calibrated as previously described [ 161 with 
specially chosen fragments of the encephalitogenic 
to provide standard peptides with similar conforma- 
tional and charge density characteristics. The fraction 
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Fig. 1. Polyacrylamide gel electrophoresis pattern of the 
purified fractions. The first two photos show the patterns 
obtained with peptide 154-170 when stained with amido 
black 10B (left photo) and Coomassie blue and the third 
photo shows peptide 134-150 stained with Coomassie blue. 
The last peptide did not stain with amino black 10B. 10 ng 
was applied to each gel and migration is from the top to the 
bottom of the figure. The dark broad band in the cathodic 
end of the gels stained with Coomassie blue was obtained 
with gels without any sample applied and thus is not an im- 
purity of the peptide. 
corresponding to molecules composed of 15 to 20 
amino acids (the second of three major peptide peaks) 
was collected and further separated by chromatography 
on CM-Sephadex C-50 (1 .O X 10 cm) with the aid of a 
linearly increasing gradient of ammonium acetate 
buffer at pH 5 ranging from 0.02 M to 0.5 M. In the 
later part of the chromatogram, two major peaks 
emerged well separated from each other. Rechromato- 
graphy of these fractions under identical conditions 
provided the final preparations. They showed a very 
little contamination when examined in a sensitive gel 
electrophoretic system. This gel electrophoretic method 
is a slight modification of the one described by 
Ahlroth and Mutt [ 171 . The basic proteins/peptides 
migrate towards the cathode in 15% gels, and the 
staining solution, Amido black 10 B or Coomassie 
blue migrate in the opposite direction. 
Fig. 1 gives the electrophoresis patterns obtained. 
Amino acid analyses, performed as previously described 
[ 151, of the two fractions are given in table 1. An 
excellent correspondence can be seen between the 
figures obtained for the first eluting CM-Sephadex 
Table 1 
Amino acid composition of the purified fractions used in the 
present investigation. 
Amino acid residues in each peptide molecule 
134-150 154-170 154-167 
J-Ys 2.8 (3) 1.1 (1) 1.2 (1) 
His 1.9 (2) 
Arg 4.2 (4) 2.1 (2) 
Asp 1.1 (1) 1.2 (1) 1.0 (1) 
Thr 0.9 (1) L trace 
Ser 0.9 (1) 2.5 (3) 3.2 (3) 
Glu 1.0 (1) trace 
Pro 0.7 (1) 1.6- (1) 
GlY 2.6 (3) 3.1 (3) 3.4 (3) 
Ala 1.9 (2) 1.2 (1) 
Met 0.7 (1) 
Leu 1.6 (2) 0.9 (1) 1.1 (1) 
Phe 0.8 (1) 0.8 (1) 
The analyses were performed in a Beckman 12O.C analyser after 
hydrolyses in 6 N HCl at 110” for 22 hr. No corrections were 
made for hydrolytic losses. Also included in the table is the 
number of residues of regions 134-150, 154-170, and 154- 
167, respectively, according to the primary sequence. These 
figures are given in brackets. The composition of another 
preparation of the peptides has been given previously [ 161. 
fraction and the figures expected from the amino acid 
sequence of region 154- 170 [ 1,3] . The same is valid 
for the second fraction and region 135-150. The first 
fraction has an N-terminal phenylalanine, which is in 
accordance with its identification as peptide 154-170, 
but we were unable to identify the N-terminal residue 
of the second fraction with the use of the DNS- 
method as previously described [ 151. 
Tyrosine is situated in position 134 in the intact 
protein [ 1,3] but only traces of tyrosine could be 
detected in the amino acid analyses of the present 
peptide. The cleaving reaction used to prepare frag- 
ment 117- 170 is known to oxidize almost completely 
the two tyrosine residues in it [ 151 and in the amino 
acid analyses of another preparation of this peptide, a 
substantial amount of an unknown substance was 
observed. Moreover, the AiY& value at 280 nm was 
determined to 10, which shows that a W-light 
absorbing moiety is part of the peptide. It is thus con- 
cluded that this peptide constitutes region 134- 150 
in which the tyrosine residue has been oxidized. We 
do not know the nature of the oxidation product. 
Volume 23, number 2 FEBS LETTERS June 1972 
Table 2 
Encephalitogenic activity in rabbits of the three purified 
peptides. 
Peptide injected 
Number of animals showing disease/ 
number of animals challenged 
134-150 
20 /Jg 
154-170 
20 CLg 
154-170 
100 /Jg 
154-167 
100 /Jg 
419 (3/g) 
4/10 (3/10) 
215 Gv5) 
119 @/9) 
The peptides were injected into the animals as described in the 
text. The figures given are number of animals showing clinical 
disease/number of injected animals. In brackets are given the 
corresponding ratios of animals showing histological signs of 
disease to total numbers of animals. 
Cyanogen bromide cleavage was performed with 7 mg 
of peptide 154-170 in 1 ml of 70% formic acid to 
which 100 mg of CNBr was added. The reaction was 
allowed to take place for 24 hr at room temp. The 
products were lyophilized and separated on CM- 
Sephadex (1.9 X 10 cm) with the same gradient of 
ammonium acetate buffer as described above. Peptide 
168-170 eluted well ahead of peptide 154-167. The 
recovery of peptide 154-167 was almost of the 
theoretical yield. Table 1 gives the amino acid 
analyses of peptide 154- 167. 
Random bred rabbits were injected with the 
peptide preparations in the toe pads of three legs. The 
peptide solutions were emulsified with equal parts of 
Freund’s complete adjuvant (Difco). Table 2 lists the 
total amount of antigen (in 3 X 0.05 ml) given to each 
animal. The animals were observed daily and killed for 
histological examinations when showing signs of 
clinical disease or 4 weeks after challenge. 
Table 2 shows that both peptide 134-150 and 
154-170 are encephalitogenic when injected into 
rabbits. Both peptides were tested with material from 
two different preparations and no obvious difference 
in activity between the preparations was observed. 
Peptide 154-l 67 induced disease in only one animal 
out of nine when tested in 5-fold amounts compared 
with peptide 154-170. In most animals, paresis 
tended to develop late, seldom before the 20th day 
after challenge. 
3. Discussion 
The finding in the present investigation that the 
encephalitogenic activity of the C-terminal region of 
bovine myelin basic protein when tested in rabbits 
can be traced to two different regions, 134-150 and 
154- 170, respectively, merits some comments. Up to 
the present, five different regions in the entire protein 
have been ascribed encephalitogenic activity in rabbits. 
The activity of three of these - the tyrosine containing 
region l-20, the site around the tyrosine residue in 
position 68, and the tryptophan containing region - 
may, according to Shapira et al. [ 1 l] , be dependent 
on the common presence of an aromatic residue 
localized in the neighbourhood of a Gln-Lys (or 
Gln-Arg) sequence. In the two most active sites. the 
Gln-Lys residues are situated 5-6 residues C-terminal 
to the aromatic residue. These two sites are extremely 
similar in shape [ 111 . 
In the present case, it is clear from the amino acid 
sequence of the peptide that the activity cannot be 
ascribed to such properties. As fig. 2 shows, there are 
no apparent similarities between the peptides. The 
activity of region 154-170 does not seem to be com- 
pletely destroyed when it is cleaved at the methionine 
residue. This would indicate that an intact structure 
of the C-terminal part of the peptide is probably not 
absolutely essential for activity. The preparation of 
Tyr-Lys-Ser-Ala-His-Lys-Gly-Leu-Lys-Gly-His-Asp-Ala-Gln--Gly-Thr-Leu 
134 140 150 _ 
Phe-Lys-LeuGly-Gly-Arg-Asp-Ser - Arg-Ser-Gly-Ser -Pro-Met-Ala-Arg-Arg 
154 160 170 
Fig. 2. Amino acid sequences of peptides 134-150 and 154-170 (bottom) as determined by Eylar et al. [ 1,3]. 
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substantial amounts of the peptides is rather tedious, 
which means that a closer examination of the active 
sites in these regions will probably await synthesis of 
these and analogous peptides. This is further borne 
out by the fact that the peptides seem unsuitable for 
specific chemical modification. 
Recently, both of the peptides described in the 
present investigation have been shown to contain 
antigenic determinants capable of reacting in the 
macrophage migration inhibition assay in guinea-pig, 
a test which is usually considered as an in vitro 
correlate of delayed hypersensitivity. It is thus 
probable that one or both of these regions are also 
responsible for the very slight encephalitogenic 
activity in guinea-pigs of the C-terminal third of the 
protein that has been observed [ 121. 
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